These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8148364

  • 1. Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping.
    Coutts RT.
    J Psychiatry Neurosci; 1994 Jan; 19(1):30-44. PubMed ID: 8148364
    [Abstract] [Full Text] [Related]

  • 2. Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.
    Vandel P, Haffen E, Nezelof S, Broly F, Kantelip JP, Sechter D.
    Hum Psychopharmacol; 2004 Jul; 19(5):293-8. PubMed ID: 15252821
    [Abstract] [Full Text] [Related]

  • 3. No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
    Roberts RL, Mulder RT, Joyce PR, Luty SE, Kennedy MA.
    Hum Psychopharmacol; 2004 Jan; 19(1):17-23. PubMed ID: 14716707
    [Abstract] [Full Text] [Related]

  • 4. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T, Price A.
    Am Fam Physician; 2007 Aug 01; 76(3):391-6. PubMed ID: 17708140
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K, Tybring G, Härtter S, Andersson K, Svensson JO, Widén J, Bertilsson L.
    Clin Pharmacol Ther; 2001 Oct 01; 70(4):327-35. PubMed ID: 11673748
    [Abstract] [Full Text] [Related]

  • 6. The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.
    Skjelbo E, Gram LF, Brøsen K.
    Br J Clin Pharmacol; 1993 Mar 01; 35(3):331-4. PubMed ID: 8471415
    [Abstract] [Full Text] [Related]

  • 7. High blood concentrations of imipramine or clomipramine and therapeutic failure: a case report study using drug monitoring data.
    Balant-Gorgia AE, Balant LP, Garrone G.
    Ther Drug Monit; 1989 Mar 01; 11(4):415-20. PubMed ID: 2741190
    [Abstract] [Full Text] [Related]

  • 8. Rates of in vivo methylation of desipramine and nortriptyline.
    Kurpius MP, Alexander B.
    Pharmacotherapy; 2006 Apr 01; 26(4):505-10. PubMed ID: 16553509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Assessment of CYP2D6 activity as a form of optimizing antidepressant therapy].
    Szewczuk-Bogusławska M, Grzesiak M, Beszłej JA, Kiejna A.
    Psychiatr Pol; 2004 Apr 01; 38(6):1093-104. PubMed ID: 15779673
    [Abstract] [Full Text] [Related]

  • 11. Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation.
    Sjöqvist F, Bertilsson L.
    Prog Clin Biol Res; 1986 Apr 01; 214():169-88. PubMed ID: 3523507
    [Abstract] [Full Text] [Related]

  • 12. Lack of pharmacokinetic interaction between dextromethorphan, coumarin and mephenytoin in man after simultaneous administration.
    Endres HG, Henschel L, Merkel U, Hippius M, Hoffmann A.
    Pharmazie; 1996 Jan 01; 51(1):46-51. PubMed ID: 8999435
    [Abstract] [Full Text] [Related]

  • 13. Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?
    Vandel P, Haffen E, Vandel S, Bonin B, Sechter D, Bizouard P, Dalery J.
    Therapie; 2000 Jan 01; 55(3):349-53. PubMed ID: 10967711
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic drug monitoring of psychotropic drugs in children.
    Morselli PL, Bianchetti G, Dugas M.
    Pediatr Pharmacol (New York); 1983 Jan 01; 3(3-4):149-56. PubMed ID: 6146122
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
    Botsch S, Gautier JC, Beaune P, Eichelbaum M, Kroemer HK.
    Mol Pharmacol; 1993 Jan 01; 43(1):120-6. PubMed ID: 8423765
    [Abstract] [Full Text] [Related]

  • 16. Genetic polymorphism of S-mephenytoin 4'-hydroxylation.
    Daniel HI, Edeki TI.
    Psychopharmacol Bull; 1996 Jan 01; 32(2):219-30. PubMed ID: 8783891
    [Abstract] [Full Text] [Related]

  • 17. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.
    Koyama E, Chiba K, Tani M, Ishizaki T.
    J Pharmacol Exp Ther; 1997 Jun 01; 281(3):1199-210. PubMed ID: 9190854
    [Abstract] [Full Text] [Related]

  • 18. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I, Beresewicz M, Puzyński S, Kalinowski A.
    Psychiatr Pol; 1994 Jun 01; 28(1):27-38. PubMed ID: 8190817
    [Abstract] [Full Text] [Related]

  • 19. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.
    Ingelman-Sundberg M.
    Pharmacogenomics J; 2005 Jun 01; 5(1):6-13. PubMed ID: 15492763
    [Abstract] [Full Text] [Related]

  • 20. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR, Nemeroff CB.
    Depress Anxiety; 1998 Jun 01; 7 Suppl 1():24-32. PubMed ID: 9597349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.